Global Cord Blood Corporation (CORBF)

Global Cord Blood Balance Sheet

Financials in millions CNY. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Cash & Equivalents	6,661	6,661	6,076	5,473	4,998	4,251
Cash & Cash Equivalents	6,661	6,661	6,076	5,473	4,998	4,251
Cash Growth	9.63%	9.63%	11.01%	9.51%	17.58%	21.09%
Receivables	465.25	465.25	347.51	264.28	201.78	209.63
Inventory	141.04	141.04	135.7	128.87	104.81	99.48
Other Current Assets	-332.27	-332.27	-260.87	-200.36	-156.52	-151.29
Total Current Assets	6,935	6,935	6,298	5,666	5,148	4,408
Property, Plant & Equipment	476.69	476.69	503.7	527.23	545.34	552.96
Long-Term Investments	282.3	282.3	307.04	290.44	296.49	343.01
Goodwill and Intangibles	83.58	83.58	88.2	92.82	97.44	102.07
Other Long-Term Assets	756.95	756.95	709.25	643.2	463.75	437.98
Total Long-Term Assets	1,600	1,600	1,608	1,554	1,403	1,436
Total Assets	8,535	8,535	7,906	7,220	6,551	5,844
Accounts Payable	8.33	8.33	9.48	19.99	33.57	11.37
Deferred Revenue	2,932	2,932	2,842	2,693	2,570	2,240
Current Debt	0.15	0.15	1.64	1.72	0	0
Other Current Liabilities	-2,293.73	-2,293.73	-2,226.91	-2,143.44	-2,008.35	-1,783.58
Total Current Liabilities	646.56	646.56	626.47	570.78	595.64	468.18
Long-Term Debt	0	0	0.15	1.78	0	0
Other Long-Term Liabilities	3,003	3,003	2,891	2,759	2,533	2,258
Total Long-Term Liabilities	3,003	3,003	2,891	2,761	2,533	2,258
Total Liabilities	3,650	3,650	3,518	3,331	3,128	2,726
Total Debt	0.15	0.15	1.78	3.5	0	0
Debt Growth	-91.76%	-91.76%	-49.04%	-	-	-
Retained Earnings	2,887	2,887	2,386	1,878	1,407	1,117
Comprehensive Income	-106.79	-106.79	-103.18	-94.66	-88.74	-54.65
Shareholders' Equity	4,879	4,879	4,382	3,882	3,417	3,113
Net Cash / Debt	6,661	6,661	6,074	5,470	4,998	4,251
Net Cash / Debt Growth	9.66%	9.66%	11.04%	9.44%	17.58%	71.46%
Working Capital	6,288	6,288	5,672	5,095	4,552	3,940
Book Value Per Share	40.10	40.10	36.01	31.94	28.28	27.42

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).